IDH2 and oligodendroglioma: Venteicher et al. (2017) performed scRNA-seq analysis of IDH-mut astrocytomas (IDH-A) characterized by TP53 and ATRX mutations, and oligodendrogliomas (IDH-O) characterized by mutations in the TERT (Telomerase reverse transcriptase) gene promoter and co-deletion of chromosome arms 1p and 19q (1p/19q) [13].